Snowball logo
logo
XERS_logo

Xeris Pharmaceuticals Inc

XERS β€’ NASDAQ
$10.21+$0.01Β  (0.1%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
49.59110.2163.9203.1291.8335.4
COGS
13.3222.6328.6436.8353.4155.87
Gross Profit
36.2787.61135.3166.2238.4279.5
Operating Expenses & Income
Operating Income
(115.2)(81.94)(44.01)(33.65)24.936.59
Total Operating Expenses
151.4169.6179.3199.9213.5242.9
R&D Expenses
25.1620.9722.3425.5631.1634.81
Selling General & Admin Expenses
125.7137.7146.1163.5182.4208.1
Earnings from Continuing Operations
Interest Expense
(7.18)(14.1)(26.61)(33.17)(29.08)(28.25)
Interest Income
0.3132.5784.7515.3214.7425.276
Income Tax Expense
(0.11)(1.424)(1.249)(2.268)--
Net Income
Net Income
(122.7)(94.66)(62.26)(54.84)0.554(17.16)
Supplemental
EBIT
(115.5)(81.98)(36.9)(26.62)0.5543.934
EBITDA
(113.7)(69.31)(23.73)(13.99)12.7116.59
In millions of USD, except % and values per 1 share